Evidence map›Paper›PMID 42608390›Full record

ArticleBlood cancer journal2026

Determinants of survival after failure of frontline venetoclax plus hypomethylating agent therapy in 356 patients with newly diagnosed acute myeloid leukemia.

Mahnoor Fatima, Sudhesh Kumar, Momna Warraich, Kristen McCullough, Aref Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Abhishek Mangaonkar, Antoine N Saliba, Mark R Litzow and 10 more

Abstract readLetter
In one paragraph

Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Mahnoor FatimaDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0009-0004-2521-6497
Sudhesh KumarDivision of Hematology, Mayo Clinic, Rochester, MN, USA.
Momna WarraichDivision of Hematology, Mayo Clinic, Rochester, MN, USA.
Kristen McCulloughDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0003-4252-2619
Aref Al-KaliDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-0824-3715
Hassan B AlkhateebDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-3609-8404
Kebede H BegnaDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0003-2730-8593
Abhishek MangaonkarDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0003-2458-9887
Antoine N SalibaDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-5134-7336
Mark R LitzowDivision of Hematology, Mayo Clinic, Rochester, MN, USA.
William HoganDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-5841-4105
Mithun V ShahDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-5359-336X
Mrinal M PatnaikDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-6998-662X
Animesh PardananiDivision of Hematology, Mayo Clinic, Rochester, MN, USA.
Talha BadarDivision of Hematology, Mayo Clinic, Jacksonville, FL, USA.ORCID http://orcid.org/0000-0003-1548-918X
James ForanDivision of Hematology, Mayo Clinic, Jacksonville, FL, USA.ORCID http://orcid.org/0000-0003-1673-1708
Jeanne PalmerDivision of Hematology, Mayo Clinic, Scottsdale, AZ, USA.
Cecilia Arana YiDivision of Hematology, Mayo Clinic, Scottsdale, AZ, USA.
Ayalew TefferiDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0003-4605-3821
Naseema GangatDivision of Hematology, Mayo Clinic, Rochester, MN, USA. gangat.naseema@mayo.edu.ORCID http://orcid.org/0000-0002-9104-6172

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42608390
PMCPMC13483032

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.